Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12

International Journal of Cancer

Volumn 140, Issue 2, 2017, Pages 302-309

  Chimed, Tuvshinjargal ^a   Sandagdorj, Tuvshingerel ^b   Znaor, Ariana ^a   Laversanne, Mathieu ^a   Tseveen, Badamsuren ^b   Genden, Purevsuren ^b   Bray, Freddie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b National Cancer Center   (Mongolia)

Author keywords

cancer control; cancer incidence; cancer registry; epidemiology; Mongolia

Indexed keywords

ADOLESCENT; ADULT; AGED; AIR POLLUTION; ALCOHOL CONSUMPTION; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CHILD; CHINA; CHRONIC HEPATITIS; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENDER; HUMAN; INFANT; LIFESTYLE MODIFICATION; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONGOLIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RUSSIAN FEDERATION; SCHOOL CHILD; STOMACH CANCER; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; YOUNG ADULT; INCIDENCE; NEOPLASMS; NEWBORN; REGISTER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MONGOLIA; NEOPLASMS; REGISTRIES; RUSSIA; YOUNG ADULT;

EID: 84995955778     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30463     Document Type: Article

References (56)

1. MOH. Health Indicators 2012. Ulaanbaatar: Center for Health Development, Ministry of Health Mongolia, 2012.
2. Kohrt BA, Hruschka DJ, Kohrt HE, et al. Distribution of distress in post-socialist Mongolia: a cultural epidemiology of yadargaa. Soc Sci Med 2004;58:471–85.
3. Tsilaajav T, Ser-Od E, Baasai B, et al. Mongolia Health System Review. Manila: World Health Organization Regional Office for the Western Pacific, 2013.
4. Ulikpan A, Mirzoev T, Jimenez E, et al. Central Asian Post-Soviet health systems in transition: has different aid engagement produced different outcomes? Glob Health Action 2014;7:24978
5. WHO. Noncommunicable diseases country profiles 2014. Geneva: World Health Organization, 2014.
6. Shin H-R, Carlos MC, Varghese C. Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol 2012;42:867–81.
7. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385:977–1010.
8. Moore MA, Aitmurzaeva G, Arsykulov ZA, et al. Chronic disease prevention research in Central Asia, the Urals, Siberia and Mongolia - past, present and future. Asian Pac J Cancer Prev 2009;10:987–96.
9. Sandagdorj T, Sanjaajamts E, Tudev U, et al. Cancer incidence and mortality in Mongolia - National Registry Data. Asian Pac J Cancer Prev 2010;11:1509–14.
10. Jensen O, Parkin D, MacLennan R, Muir C, Skeet R, eds. Cancer Registration: principles and Methods. Lyon: International Agency for Research on Cancer (IARC Scientific Publications, No. 95), 1991.
11. MOH. National Cancer Control Program 2007-2017 Mongolia. Ulaanbaatar: Ministry of Health of Mongolia, 2007.
12. Chimeddamba O, Peeters A, Walls HL, et al. Noncommunicable disease prevention and control in Mongolia: a policy analysis. BMC Public Health 2015;15:660
13. Cancer Registry Guidelines of Mongolia. Ministry of Health of Mongolia, 2012.
14. WHO. Technical Meeting on Raising Awareness, Surveillance, Prevention and Management of Viral Hepatitis in Mongolia. Manila: World Health Organization Regional Office for the Western Pacific, 2014.
15. MOH. Liver cancer strategy. Ulaanbaatar: Ministry of Health of Mongolia, 2014.
16. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013. Available at: http://globocan.iarc.fr (accessed on March 25, 2016)
17. McGlynn KA, London WT. International liver cancer incidence trends–letter. Cancer Epidemiol Biomarkers Prev 2012;21:384–5. author reply 386.
18. Alcorn T. Mongolia's struggle with liver cancer. Lancet 2011;377:1139–40.
19. Jazag A, Puntsagdulam N, Chinburen J. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia. Korean J Intern Med 2012;27:121–7.
20. Oyunsuren T, Sanduijav R, Davaadorj D, et al. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia. Asian Pacific J Cancer Prev 2006;7:460–2.
21. Oyunsuren T, Kurbanov F, Tanaka Y, et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses. J Med Virol 2006;78:1688–95.
22. Dondog B, Lise M, Dondov O, et al. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Eur J Cancer Prev 2011;20:33–9.
23. Tsatsralt-Od B, Takahashi M, Nishizawa T, et al. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005;77:491–9.
24. Dorzhgotov B. Risk factors in the manifestations of the 5 principal forms of cancer in the People's Republic of Mongolia. Sante Publique (Bucur) 1989;32:361–7.
25. Shin H-R, Shin A, Woo H, et al. Prevention of infection-related cancers in the WHO Western Pacific Region. Jpn J Clin Oncol 2016;46:13–22.
26. de Martel C, Maucort-Boulch D, Plummer M, et al. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 2015;62:1190–200.
27. Armstrong SC, Tsogtbaatar B. The dual nature of alcohol use and abuse in Mongolia: reflections through policy. Asia Pac J Public Health 2010;22:209S–215S.
28. WHO. Mongolia: WHO and UNICEF estimates of immunization coverage: 2015 revision [Internet]. 2016. Available at: http://www.who.int/immunization/monitoring_surveillance/data/mng.pdf(accessed on September 16, 2016)
29. Abbas Z, Abbas M, Abbas S, et al. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015;7:777–86.
30. Colquhoun A, Arnold M, Ferlay J, et al. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut 2015;64:1881–8.
31. Goh L-YY, Leow AHR, Goh K-LL. Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region. J Dig Dis 2014;15:463–8.
32. Correa P. Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev 2003;12:238s–241s.
33. IARC. Monographs on the evaluation of carcinogenic risks to humans Volume 100 B: a review of human carcinogens: biological agents. Lyon, France: International Agency for Research on Cancer, 2012.
34. Anarkhuu B, Munguntsetseg B, Khosbayar T, et al. Detection of Helicobacter pylori virulence factors and interleukin-1 polymorphisms in patients with abdominal complaint. World J Nucl Med 2007;6:S73–4.
35. Matsuhisa T, Yamaoka Y, Uchida T, et al. Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection. World J Gastroenterol 2015;21:8408–17.
36. Arnold M, Soerjomataram I, Ferlay J, et al. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015;64:381–7.
37. IARC. Monographs on the evaluation of carcinogenic risks to humans Volume 100 E: a review of human carcinogens: personal habits and indoor combustions. Lyon, France: International Agency for Research on Cancer, 2012.
38. Moore MA, Sobue T. Strategies for cancer control on an organ-site basis. Asian Pac J Cancer Prev 2010;11:149–64.
39. Long N, Moore MA, Chen W, et al. Cancer epidemiology and control in north-East Asia—past, present and future. Asian Pac J Cancer Prev 2010;11Suppl 2:107–48.
40. Melhado RE, Alderson D, Tucker O. The changing face of esophageal cancer. Cancers (Basel) 2010;2:1379–404.
41. Ma S-H, Jung W, Weiderpass E, et al. Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status. Br J Cancer 2015;113:1381–8.
42. WHO. Mongolian STEPS survey on the prevalence of noncommunicable disease and injury risk factors—2009. World Health Organization, 2010.
43. Malfertheiner P, Megraud F, O 'Morain CA, et al. Management of Helicobacter pylori infectiondthe Maastricht IV/Florence Consensus Report. Gut 2012;61:646–64.
44. Shi J-FF, Qiao Y-LY-LL, Smith JS, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine 2008;26:M53–9.
45. Moore M, Tajima K. Cervical cancer in the asian pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev 2003;5:349–61.
46. Sloan FA, Gelband H, eds. Cancer causes and risk factors and the elements of cancer control. In: Cancer control opportunities in low- and middle-income countries. Washington, DC: The National Academies Press, 2007. 27–69.
47. Dondog B, Clifford GM, Vaccarella S, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008;17:1731–8.
48. Chimeddorj B, Pak CY, Damdin A, et al. Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia. Asian Pacific J Cancer Prev 2008;9:563–8.
49. Konno R, Sagae S, Yoshikawa H, et al. Cervical Cancer Working Group report. Jpn J Clin Oncol 2010;40: i44–50.
50. Varghese C, Carlos MC, Shin H-R. Cancer burden and control in the western pacific region: challenges and opportunities. Ann Glob Heal 2014;80:358–69.
51. IARC. Monographs on the evaluation of carcinogenic risks to humans Volume 109: outdoor Air Pollution. Lyon, France: International Agency for Research on Cancer, 2016.
52. World Bank. Air quality analysis of Ulaanbaatar: improving air quality to reduce health impacts. Washington, DC: The International Bank for Reconstruction and Development, The World Bank, 2011.
53. Allen RW, Gombojav E, Barkhasragchaa B, et al. An assessment of air pollution and its attributable mortality in Ulaanbaatar, Mongolia. Air Qual Atmos Heal 2013;6:137–50.
54. Gombojav E, Purev E, Badrakh B, et al. Indoor Air Pollution in Different Mongolian Dwellings and Children's Health in Ulaanbaatar (Mongolia). Epidemiology 2011;22:S42
55. Yerramilli P, Dugee O, Enkhtuya P, et al. Exploring knowledge, attitudes, and practices related to breast and cervical cancers in Mongolia: a national population-based survey. Oncologist 2015;20:1266–73.
56. Sutcliffe S. National cancer control plans. In: Stewart B, Wild C, eds. World Cancer Report 2014. Lyon: International Agency for Research on Cancer, 2014. 529–36.